NCT04022941View on ClinicalTrials.gov

Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Chronic Liver Disease
Interventions
DRUG

Sodium Benzoate

Group A will receive drug packets containing 2.5 gm sodium benzoate and 5 gm powdered table sugar for 5 days.

OTHER

Powdered table sugar as palcebo

Group B will receive 7.5 gm packets of powdered table sugar for 5 days as placebo which is similar in appearance and taste as sodium benzoate.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT04022941 - Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease. | Biotech Hunter | Biotech Hunter